ms SAMANTHA CYRULNIK-DERCHER

The link between immigrant justice and reproductive reproductive freedom; H.R.4104 and S.2149, the Health Equity & Access under the Law (HEAL) for Immigrant Families Act of 2025, which would remove political interference and restore coverage so immigrants in the United States could participate in the health insurance programs for which they would be eligible but for their immigration status or length of stay.

The link between immigrant justice and reproductive reproductive freedom; H.R.4104 and S.2149, the Health Equity & Access under the Law (HEAL) for Immigrant Families Act, which would remove political interference and restore coverage so immigrants in the United States could participate in the health insurance programs for which they would be eligible but for their immigration status or length of stay.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Access to evidence-based medication abortion care; Anti-abortion centers/crisis pregnancy centers, including H.R.10356 the Empowering Moms Act; Administrative actions that restrict contraceptive access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The intersection of reproductive freedom, democracy, and voting rights; H.R.7296 and S. 1383, and H.R.22, the Safeguard American Voter Eligibility (the SAVE America or SAVE) Act; S.5076, Supreme Court Biennial Appointments and Term Limits Act of 2026.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The intersection of reproductive freedom, democracy, and voting rights; H.R.7296 and S. 1383, and H.R.22, the Safeguard American Voter Eligibility (the SAVE America or SAVE) Act; S.5076, Supreme Court Biennial Appointments and Term Limits Act of 2026.

The link between immigrant justice and reproductive reproductive freedom; H.R.4104 and S.2149, the Health Equity & Access under the Law (HEAL) for Immigrant Families Act, which would remove political interference and restore coverage so immigrants in the United States could participate in the health insurance programs for which they would be eligible but for their immigration status or length of stay.

The link between immigrant justice and reproductive reproductive freedom; H.R.4104 and S.2149, the Health Equity & Access under the Law (HEAL) for Immigrant Families Act of 2025, which would remove political interference and restore coverage so immigrants in the United States could participate in the health insurance programs for which they would be eligible but for their immigration status or length of stay.

The link between immigrant justice and reproductive reproductive freedom; H.R.4104 and S.2149, the Health Equity & Access under the Law (HEAL) for Immigrant Families Act, which would remove political interference and restore coverage so immigrants in the United States could participate in the health insurance programs for which they would be eligible but for their immigration status or length of stay.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Access to evidence-based medication abortion care; Anti-abortion centers/crisis pregnancy centers, including H.R.10356 the Empowering Moms Act; Administrative actions that restrict contraceptive access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The intersection of reproductive freedom, democracy, and voting rights; H.R.7296 and S. 1383, and H.R.22, the Safeguard American Voter Eligibility (the SAVE America or SAVE) Act; S.5076, Supreme Court Biennial Appointments and Term Limits Act of 2026.

Funding for international family planning programs; S.5565 and H.R.10600, Abortion is Health Care Everywhere Act of 2026.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.